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In Brief Krukenberg et al. found that extracellular poly(ADP-ribose) activated cytokine secretion and phagocytosis in human and mouse macrophages through Toll-like receptors 2 and 4. This provides evidence of an extracellular function of poly(ADPribose).
INTRODUCTION
Poly(ADP-ribose) ( Figure 1A ), a unique post-translational modification, is synthesized by poly(ADP-ribose) polymerases (PARPs). ADP-ribose subunits are attached to acceptor proteins using NAD + as a substrate (Diefenbach and Burkle, 2005) . Additional ADP-ribose subunits are added to elongate the chain (Altmeyer et al., 2009 ). Chain length is variable and up to 200 units in length in vitro (D'Amours et al., 1999) . Inside cells, PAR chains are rapidly cleaved by poly(ADP-ribose) glycohydrolase (PARG), TARG1, and other hydrolases such as phosphodiesterases (PDE) ( Figure 1A ) (Diefenbach and Burkle, 2005; Hassa and Hottiger, 2008; Perina et al., 2014) . However, PAR is chemically quite stable. It is stable in 1 M NaOH (Tan et al., 2012) and might persist longer in the extracellular space. Notably, all proposed functions of PAR are inside the cell. Possible extracellular biology has not been investigated to our knowledge. PAR and PARPs have been most studied in the DNA damage response. PARP1, the most abundant family member, is activated by direct binding to strand breaks (Langelier et al., 2012; Tallis et al., 2014) , increasing PARP1 activity 10-to 500-fold (D'Amours et al., 1999) . Activation leads to modification of PARP1 itself and other proteins in the DNA repair pathway (Chapman et al., 2013; Daniels et al., 2014; Jungmichel et al., 2013; Zhang et al., 2013) . It has been hypothesized that excessive DNA damage leads to PARP1-dependent cell death via necrosis (Ha and Snyder, 1999) , whereas PARP1 is cleaved and inactivated early in apoptosis (Kaufmann et al., 1993) .
We hypothesized that PAR acts as a signaling molecule alerting the innate immune system to necrotic cells. PAR shares some structural motifs with DNA and ATP, both of which, when exposed to the extracellular space, stimulate phagocytosis via monocyte-derived dendritic cells (Cohen and Mosser, 2013; Haag et al., 2007; Kroemer et al., 2013) . Could PAR be a substrate for extracellular receptors and act as an additional signal? To test this hypothesis, we treated mouse macrophages and primary human macrophages with purified PAR and found that PAR activated both mouse and human macrophages. This study suggested that extracellular PAR could promote phagocytosis of PAR-modified cell debris and inflammatory cytokine production by immune cells.
RESULTS

Extracellular PAR Activates a Mouse Macrophage Cell Line
Macrophages respond to infection or cellular damage by engulfing foreign cells, dead cells, or debris. They detect molecular patterns and in response, secrete pro-or anti-inflammatory cytokines, orchestrating innate immune and inflammatory responses (Murray and Wynn, 2011) . To determine if extracellular PAR could activate macrophages, we treated a standard mouse macrophage cell line (RAW264.7) with enzymatically synthesized and purified PAR (Tan et al., 2012) in the medium and measured secretion of 23 cytokines ( Figure 1B) . PAR strongly stimulated secretion of tumor necrosis factor alpha (TNFa), MCP-1, eotaxin, MIP-1a, and MIP-1b, all pro-inflammatory cytokines that are stimulated by the pathogen-associated molecular patterns (PAMPs) lipopolysaccharide (LPS), CpG DNA, and poly(I-C) RNA, known activators of innate immune responses (Caskey et al., 2011; Hä cker et al., 2002) .
RAW264.7 cells are sensitive to low levels of bacterial endotoxins such as LPS. To exclude the possibility that our purified PAR had endotoxin contamination, we digested purified PAR with snake venom PDE or bovine PARG and treated RAW264.7 cells with the digested polymer. Neither PDE nor PARG alone induced TNFa secretion when added to cells, and PAR digestion led to reduced TNFa and MCP-1 secretion upon treatment (Figures 1B and 1C ; Figure S1 ). We concluded that macrophage activation was not caused by endotoxin contamination. TNFa showed the most robust and PAR-specific response in a panel of 23 mouse cytokines ( Figure 1B ). It is also an extremely important pro-inflammatory cytokine in humans. We focused on experiments using TNFa secretion as a readout. First, we treated RAW264.7 cells with increasing concentrations of PAR for 2 and 4 hr and measured the secretion of TNFa. TNFa secretion showed a robust time and dose dependence for PAR ( Figure 1D ). PAR concentrations in all plots are expressed in units of the monomer, ADP-ribose.
We next explored the structure-activity relationship between PAR and immune cell activation. We observed no TNFa secretion with single ADP-ribose subunits, nicotinamide, or NAD + . We also tested poly-deoxyriboadenosine (polydA) and poly-riboadenosine (poly-rA), which were 20 units in length, and cyclic ADP-ribose (cADPr), a known secondary messenger. These molecules have similar structural motifs to PAR but did not induce TNFa secretion (Figures 2A and 2B) . These experiments suggested that RAW264.7 macrophages recognized a specific structural moiety found in PAR.
To better define the stimulatory motif for RAW264.7 cells, we explored the size requirements for PAR-dependent activation of these cells. By treating cells with size-fractionated PAR (Tan et al., 2012) , we found that small (2-to 17-mer), medium (18-to 40-mer), and large (>40-mer) polymers induced TNFa secretion ( Figure 2C ). Because PAR concentration is expressed in units of the monomer, the concentration of polymer decreases as size increases. This may account for the decrease in TNFa secretion seen with longer polymers. We also tested purified PAR dimers and trimers, and both induced TNFa secretion as well as bulk polymer ( Figure 2D ).
We concluded that PAR activated RAW264.7 macrophages in a manner similar to known PAMPs. We also concluded that RAW264.7 cells recognized a structural motif found in a dimer of PAR, i.e. the shortest polymer that has the unique 2 0 -1 00 ribose-ribose linkage characteristic of PAR ( Figure 2A ). Iso-ADP-ribose, the digestion product of PDE ( Figure 1A ), contains the 2 0 -1 00 ribose-ribose linkage. The loss of activity of PDEdigested PAR ( Figure 1C ; Figure S1 ) indicated that RAW264.7 cells recognized more than just the ribose-ribose linkage.
PAR Acts through Toll-like Receptors to Activate Macrophages
We next explored the mechanism of PAR-dependent TNFa secretion. TNFa secretion is often activated in response to signaling via Toll-like receptors (TLRs), a major family of pattern recognition receptors (Akira and Takeda, 2004) . TLR signaling often occurs during or after endocytosis of the PAMP bound to its cognate TLR (Takeda and Akira, 2005) . To test if PAR is internalized by cells, we incubated RAW264.7 cells with PAR labeled with the TAMRA fluorophore and measured uptake. High-performance liquid chromatography characterization of TAMRA-PAR is shown in Figure S2A . Cells incubated with TAMRA-labeled ADP-ribose and then washed briefly exhibited no fluorescent signal, whereas cells incubated with TAMRA-PAR exhibited a fluorescent signal within 15 min of incubation ( Figures  3A and 3B) . Similar results were seen with unlabeled PAR visualized by immunofluorescence ( Figure S2B ). Immunofluorescence of the PAR-treated cells with the anti-PAR 10H antibody indicated that the internalized PAR remained intact ( Figure S2B and S2D). To confirm that TAMRA-PAR behaved like unlabeled PAR, we measured TNFa secretion after TAMRA-PAR treatment. TAMRA-PAR induced TNFa secretion and secretion was blocked by digestion of TAMRA-PAR with PARG ( Figure S2E ). Uptake of TAMRA-PAR was also blocked by pre-digestion of the polymer with PDE ( Figures 3C and 3D) . The internalized PAR signal localized to punctate structures throughout the cytoplasm that concentrated near the nucleus. This is the morphology expected for endosome compartments. Staining with endosomal markers showed partial co-localization with the early endosomal marker EEA1 and no co-localization with the late endosomal marker LAMP1 (Figures 3E and 3F) . We also presented ADP-ribose or PAR attached to latex beads and performed time-lapse imaging of the cells for 3 hr after addition of the beads to the medium. RAW264.7 cells preferentially phagocytosed PAR-labeled beads (Figures 3C and S3 ; Movies S1 and S2).
To test the role of TLRs, we treated cells with small molecules that block TLR signaling. Pre-treatment of cells with the oxidized phospholipid oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (OxPAPC), which inhibits TLR2 and TLR4 by binding to specific adaptor proteins and preventing ligand binding (Erridge et al., 2008) , dramatically reduced both TNFa secretion and labeling of cells with fluorescent PAR (Figures 4A-4C) . Chloroquine, an inhibitor of endosomal acidification, which also disrupts TLR signaling by binding nucleic acid ligands (Kuznik et al., 2011) , also reduced PAR-induced TNFa secretion but to a lesser extent than OxPAPC. Chloroquine also inhibited labeling of cells with TAMRA-PAR.
To test the requirement for TLR2 versus TLR4, we treated NFkBluciferase reporter cell lines expressing either TLR2 or TLR4 with PAR. Both cell lines responded to PAR while a cell line expressing only the NFkB-luciferase reporter did not ( Figure 4D ) indicating that PAR can signal through both TLR2 and TLR4.
Extracellular PAR Activates Specific Human Macrophage Types
To test if PAR activates human primary immune cells, we isolated monocytes, precursors of macrophages, from human blood, , or TLR4 were treated with a TLR2-specific agonist, LTA-BS, a TLR4-specific agonist, LPS-B5, PAR, or ADPr. Luciferase activity was normalized by the mean of the medium-alone condition. Results are shown as the mean ± SD and n R 4. The p-value, as compared to media alone, was calculated using an unpaired t test with Welch's correction. ** = p-value between 0.001 and 0.01, ns = p-value >0.05. (E) Primary human monocytes and macrophages were treated with PAR for 6 hr before the medium was collected and analyzed for TNFa. For the second of two independent experiments, see Figure S4 . (F) Primary human monocytes and macrophages were pretreated with 30 mg/ml OxPAPC for 1 hr followed by 30 mM PAR or 1 mg/ml of LPS for 6 hr. For the second of two independent experiments, see Figure S4 . differentiated them into macrophages (M0) with M-CSF and into M1 and M2 polarized macrophages using LPS/interferon-g and IL-4, respectively. We treated the resulting four monocyte/macrophage types with PAR, and found that M0 and M2 macrophages responded to PAR by secreting TNFa, while monocytes and M1 macrophages did not ( Figures 4E,  4F , and S4). Secretion of TNFa from M0 and M2 macrophages was blocked by OxPAPC, suggesting a similar TLR2-or TLR4-dependent mechanism as seen in the mouse macrophage line (Figures 4E and  S4B ). We concluded that PAR is also a strong pro-inflammatory signal for certain primary human monocyte-derived lineages.
DISCUSSION
In this study, we found that highly purified PAR added to the medium activated both mouse and human macrophages to secrete pro-inflammatory cytokines. The activation was dose dependent and was strongly decreased by enzymatic prehydrolysis of PAR. It required a minimum of two subunits, suggesting that a cell surface receptor is recognizing, at least in part, the ribose-ribose linkage unique to PAR among standard biomolecules. TLRs are a main class of receptors for innate immune response activation in macrophages (Cohen and Mosser, 2013; Takeda and Akira, 2005) . The PAR-dependent cytokine profile closely resembled the profiles for known binders and activators of TLRs, LPS, CpG DNA, and poly(I-C) RNA (Wang et al., 2014) . PAR triggered uptake of labeled beads or internalization of fluorescently labeled PAR, and an inhibitor of TLR2 and TLR4, OxPAPC, blocked PAR-dependent TNFa secretion and the uptake of fluorescently labeled PAR. PAR induced NFkB signaling in both TLR2 and TLR4 reporter cell lines indicating that PAR can signal through both receptors. OxPAPC almost completely blocked TNFa secretion suggesting that PAR mainly signaled through either TLR2 or TLR4.
An interesting question is whether, and if so how, PAR makes its way to the extracellular space. PAR antibodies have been found in the serum of patients with Alzheimer disease and systemic lupus erythematosus (Kanai and Sugimura, 1981; Kanai et al., 2007) suggesting that PAR can become extracellular in humans. One model is that excessive activation of PARP1 through oxidative stress or DNA damage leads to cell death by necrosis. Necrotic death would expose PAR-modified acceptor proteins, or free PAR that has been cleaved off acceptors, to the extracellular space. PAR could also be made extracellularly. ART2, an enzyme found on the surface of T cells, was recently shown to synthesize PAR (Morrison et al., 2006) .
The recognition of PAR by macrophages may serve multiple biological purposes. One possibility is that this represents an alternative mechanism for activation of the innate immune response by the DNA damage response. DNA damage response signaling is known to be involved in the production of pro-inflammatory signals from damaged cells (Chatzinikolaou et al., 2014) . Unrepaired DNA damage can also trigger apoptosis generating many new DNA strand breaks through activation of caspaseactivated DNase nuclease (Samejima and Earnshaw, 2005) . PARP1 itself is cleaved early during apoptosis (Kaufmann et al., 1993) for unknown reasons. An interesting possibility is that high PARP1 activity due to caspase-activated DNaseinduced strand breaks would otherwise generate a lot of PAR, and if pro-inflammatory, this PAR would be problematic for the physiology of apoptosis. Apoptosis is thought to be a form of cell death that is not pro-inflammatory, unlike necrosis, which is highly pro-inflammatory.
SIGNIFICANCE
Overall, this study elucidated a novel extracellular function for PAR and provides an exciting connection between PAR, PARP activity, and the innate immune system. The link between PAR and the innate immune systems warrants further study and presents exciting possibilities for the role of PAR in inflammation and cancer.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents RAW264.7 cells (ATCC), 293-NFkB-Luc, 293-TLR4HA-MD2-CD14-NFkBLuc, 293-TLR2-FLAG-NFkB-Luc cell lines were grown in DMEM (Mediatech/Corning) with 10% FBS (Gibco) and 1% penicillin/streptomycin (Mediatech/Corning). Isolation and manipulation of primary human immune cells were adapted from Martinez et al. (2006) . For more details, see Supplemental Information.
PAR used in this study was purified and fractionated as previously described by Tan et al. (2012) . TAMRA (Life Technologies)-labeled PAR was synthesized by coupling the carboxyl group on TAMRA with the free amine on PAR using N-(3-dimethylaminopropyl)-N 0 -ethylcarbodiimide hydrochloride or 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM, Oakwood Products) as coupling reagents. For more details, see Supplemental Information. For PAR digestions, PAR was incubated with either 13 ng/ml bovine PARG (Enzo Life Sciences) or 2 mg/ml PDE (Affymetrix) for 2 hr at 37 C in 100 mM Tris buffer (pH 8.0).
Multiplex Cytokine Analysis RAW264.7 cells were seeded in 96-well plates and allowed to adhere overnight. Medium was then exchanged for medium containing either PAR, LPS (Sigma), CpG DNA (Invivogen), or poly(I-C) RNA (Invivogen). At each time point, medium was collected and frozen at À80 C until further analysis. Secreted cytokines were measured using the Bio-Plex Pro Mouse Cytokine 23-plex Assay (Bio-Rad) and FlexMap3D (Luminex) following the manufacturer's instructions.
TNFa ELISA Assay Cells were seeded in 96-well plates a day before treatment at a density of 1 3 10 5 cells/ml. Medium was exchanged for medium containing PAR and other stimulants. After treatment, medium was collected and stored at À80 C until analysis. Levels of secreted TNFa were measured using the BioLegend TNFa ELISA kit according to the manufacturer's instructions.
NFkB Reporter Assay
Cells were seeded in 96-well plates a day before treatment at a density of 1 3 10 5 cells/ml. Cells were treated with 30 mM PAR, 100 ng/ml LTA-BS (Invivogen), 1 ng/ml LPS-B5 ultrapure (Invivogen), or 30 mM ADPr for 24 hr. Luciferase activity was determined using the Promega Luciferase Assay system according to the manufacturer's instructions.
Imaging
For confocal imaging, Raw264.7 cells were seeded onto coverslips. After a day, cells were treated with TAMRA-labeled PAR for 30 min in a 37 C incubator and washed twice with PBS to remove residual PAR. Cells were fixed with 4% formaldehyde for 15-20 min at room temperature and kept in PBS during imaging or mounted with Prolong Gold Mounting Media (Invitrogen). Images at up to five random positions per condition were obtained. For quantification of PAR uptake, cell edges were outlined and fluorescent intensity was analyzed in single cells using ImageJ. For live cell imaging, ADP-ribose (Sigma) and purified PAR were conjugated to 1 mm carboxylated latex beads (Sigma) using DMTMM as a coupling reagent (see Supplemental Information). 2.5 3 10 5 beads/ml were added to cells growing in MatTek glass-bottom tissue culture plates and imaged. See Supplemental Information for more information on the microscope systems used.
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